Article Summary
The orthopedic industry just got handed a 10-year bill it can't ignore. For decades, arthroscopic partial meniscectomy was the go-to move for degenerative knee tears: quick, billable, and surgeon-preferred.
The problem? The Finnish FIDELITY trial just published its decade-long verdict, and it's brutal. Not only does trimming a degenerative meniscus fail to outperform a fake surgery, it actively accelerates osteoarthritis and drives patients toward total knee replacements faster.
Finland saw the data and cut procedure volumes by 90%.
The U.S.? Still doing 91,000 cases a year.
That gap between evidence and practice is where the real story lives, and it has major implications for every surgeon, hospital administrator, and device company still counting on arthroscopy volume to hold the line.
Full Article
The orthopedic industry is facing a massive wake-up call regarding one of its most reliable volume drivers. For over a decade, data has quietly chipped away at the clinical utility of arthroscopic partial meniscectomies (APM) for degenerative tears. Now, a devastating 10-year follow-up study has officially dropped a hammer on the procedure.
Writing for KFF Health ...
